Article Details

Voyager Therapeutics Announces CEO Succession Plan for 2018

Retrieved on: 2018-01-31 05:00:00

Tags for this article:

Click the tags to see associated articles and topics

Voyager Therapeutics Announces CEO Succession Plan for 2018. View article details on HISWAI:

Excerpt

<div>Prior to Voyager, Dr. Paul, 67, was also a venture partner at <b>Third Rock Ventures</b> where he helped lead the ideation and formation of new companies including Voyager and Sage Therapeutics (NASDAQ:SAGE). He spent 17 years at Eli Lilly, during which time he held several key leadership roles ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up